The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).
Opinion
Links 04/03/2026: "The EU moves to kill infinite scrolling" and a call to "Nationalize Amazon"
The high‑profile case arose against a backdrop of increasing scrutiny of alleged misuse of Strategic Lawsuits Against Public Participation (“SLAPPs”) to deter legitimate investigative reporting. The ...
Wall Street is in a downward pattern after days of volatility. Markets have been buffeted by developments in the conflict in ...
4d
Stock market today: Dow plummets, S&P 500 and Nasdaq fall as oil surges to highest levels since 2024
Wall Street is in a downward pattern after days of volatility. Markets have been buffeted by developments in the conflict in ...
How-To Geek on MSN
This book taught me 6 must-know facts about Linux
An old book about an even older operating system.
LOS ANGELES, CA, UNITED STATES, March 6, 2026 /EINPresswire.com/ -- Acclaimed author J. J. Hebert has received a major ...
Keenova Therapeutics plc announced the first-time publication of a retrospective analysis using previously generated XIAFLEX® (collagenase clostridium histolyticum) data. The analysis evaluates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results